Projects per year
Abstract
Microneedle technology can effectively suppress the formation of hypertrophic scarring in both animals and humans. Our previous research has revealed that this is due to the physical contact inhibition effect by using microneedles made of liquid-crystal polymers as the model device. One important factor we didn't study is the influence of the fabrication materials of microneedles. Therefore, this article examines this key point on a rabbit ear hypertrophic scar model. We monitor the thickness of the scars, and the expression of α-SMA and Ki-67 protein, and TGF-β1 mRNA in a period of 42 days. Among microneedles made of 6 polymeric materials and stainless steel, polymethylmethacrylate microneedles present superiority in all aspects including the reduction of tissue fibrosis, and the expression of α-SMA, Ki-67 protein and TGF-β1 mRNA. On the other hand, polycarbonates, polyurethane, and polylactic-co-glycolic acid microneedles could suppress three biomarker expressions.
© 2023 The Author(s).
© 2023 The Author(s).
| Original language | English |
|---|---|
| Pages (from-to) | 927-933 |
| Journal | Nanoscale Advances |
| Volume | 5 |
| Issue number | 3 |
| Online published | 23 Dec 2022 |
| DOIs | |
| Publication status | Published - 7 Feb 2023 |
Funding
This work was supported by the National Institutes of Health of China (AI118898). C. X. acknowledges the funding support from the City University of Hong Kong (9610472, 7020029), General Research Fund (GRF) from the University Grant Committee of Hong Kong (UGC) and the Research Grant Council (RGC) (CityU 11202021).
Research Keywords
- PRACTICAL GUIDELINES
- MANAGEMENT
Publisher's Copyright Statement
- This full text is made available under CC-BY-NC 3.0. https://creativecommons.org/licenses/by-nc/3.0/
RGC Funding Information
- RGC-funded
Fingerprint
Dive into the research topics of 'Comparison of the efficacy of seven types of microneedles for treating a rabbit hypertrophic scar model'. Together they form a unique fingerprint.Projects
- 1 Finished
-
GRF: Development of Framework Nucleic Acid based platform technology for intradermal and transdermal delivery of oligonucleotides therapeutics
XU, C. (Principal Investigator / Project Coordinator)
1/01/22 → 8/08/25
Project: Research